ã¡ãã£ã¢èšäº
ã€ãã«ã¡ã¯ãã³ã 誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ããºãææ°ããŒã¯ 424
twitterã³ã¡ã³ã 388ä»¶äž 201ïœ300件
ç§ãã¿ãã®ã¯åæ ç掟ãç¬ç«çšãè²·ãæŒã£ãŠãšãããã飲ãã§ãã£ãŠã©ãã©ããšãã€ãŒãããŠãå°çã ã£ããã
è¬ã¯åãåããªãããããäžæŠã§ã¯ãªãããã
äœèª¿æªããªã£ããç é¢ã§åŠæ¹ãããè¬é£²ãã§ãã®ãããããããªãããªã
ãšããããã蚺ãŠãããç é¢æ¢ãã®ã1çªå€§äºã ãã
äœèª¿æªããªã£ããç é¢ã§åŠæ¹ãããè¬é£²ãã§ãã®ãããããããªãããªã
ãšããããã蚺ãŠãããç é¢æ¢ãã®ã1çªå€§äºã ãã
BBCã£ãŠæ¥æ¬ã®ãããšãããããªãã£ãŠããã€ã¡ãŒãžããããªïœ
ä¿¡ããŠããããããâïž
ä¿¡ããŠããããããâïž
ã¯ããŒããªãã»ã©
ã€ãã«ã¡ã¯ãã³æšé²æŽŸã¯ãå€æ°ã®ç§åŠçç 究ãåŒçšãã蚌æ ãç¡èŠãããã¯é èœãããŠãããšäž»åŒµ
ããããç¬ç«ããç§åŠè ã°ã«ãŒãã®è©äŸ¡ã§ã¯ãç 究çµæã«å€§ããªçåãæããããããŠããã
ããããç¬ç«ããç§åŠè ã°ã«ãŒãã®è©äŸ¡ã§ã¯ãç 究çµæã«å€§ããªçåãæããããããŠããã
åã¯ã¯ãã³ã»ã€ãã«ã¡ã¯ãã³ä¿¡è
ã§ã¯ãªããã©ãã€ãã«ã¡ã¯ãã³ïŒå®¶ççšã¯è«å€ïŒãæ²»çã«æå¹ãã£ããã¯ã¯ãã³ãšã»ããã§ã³ããæ»ç¥ã«å
ãèŠããŠãããããã«æ®å¿µãã
çå±±ãã€ããæªã ã«ã€ãã«ã¡ã¯ãã³ã«æã£ãŠãã®ãæããã ããªããæ¯æè
ã«ç
œãããŠãã®ããå
å
ã§ã®å¢åäºãã«å©çšãããã®ãã
ã€ãã«ã¡ã¯ãã³ã¯å¹æãã·ãšãããã¥ãŒã¹ãã¯ã¯ãã³åŠå®è«ïŒâé°è¬è«ïŒãèªåã ãã«é©çšãããªãæå¥ã¯ãªãããã¯ã¯ãã³æ¥çš®è
ããã³ããè³ããšã誹è¬ããé£äžã¯èŠéããèš³ã«ã¯ãããªããé°è¬è«è
ã«ã¯é©åãªæ
å ±ãéããåºæ¬çãªãªãã©ã·ãŒãæ¬ ããŠããããšã«ééãã¯ãªãã
ãšããããã€ãã«ã¡ã¯ãã³ã¯æ¢ããŠãèæ ¹æ¹¯ã§ããããããªãããšã
è¬åã«ã¯ãã©ã»ãããããããªããšãèšããªãããªãâŠã
æ¬åœã«å¹ãã®ãç ã¯æ°ãããšããã®ããæ ¹æ ã¯èããšãå°ãªããšãæ²»ããšæããä¿¡ãã人ã®æ°åãåŠå®ããããšã¯ã§ãããã
æ¬åœã«å¹ãã®ãç ã¯æ°ãããšããã®ããæ ¹æ ã¯èããšãå°ãªããšãæ²»ããšæããä¿¡ãã人ã®æ°åãåŠå®ããããšã¯ã§ãããã
ã©ã¡ããæ¬åœããããããé芳
ð©èšäºã£ãŠã³ã¬ã®ããšããªã
æ²»éšã®è«æã¯æéããããŠããã¡ããšæ£ããããã»ã¹ãèžãã§è¡ãããŠæ¬²ããã
æ©ãã³ããçŠãçµããããããšæãã°ããã«äžæ£ãè¡ã£ãŠããããã£ãŠçµãããé ã®ãã ããªã®ã§ã
æ©ãã³ããçŠãçµããããããšæãã°ããã«äžæ£ãè¡ã£ãŠããããã£ãŠçµãããé ã®ãã ããªã®ã§ã
ã¡ãã£ã¢ãå
šåã§å©ããããããªãã£ãŠäºã¯âŠã
èªãã§ããçµå±ãã©ãããçç±ã§ã€ãã«ã¡ã¯ãã³æšããªã®ãïŒããåãããªãã
çŸå°å¥³æ°è¬è²æã²ãŒã ãæ¬åœã¯ã¢ã«ããã©ãã«ãã€ãã«ã¡ã¯ãã³ã¯åå€ç¡å°
çŸå°å¥³æ°è¬è²æã²ãŒã ãæ¬åœã¯ã¢ã«ããã©ãã«ãã€ãã«ã¡ã¯ãã³ã¯åå€ç¡å°
ãã£ãšäžçã®ã¡ãã£ã¢ã
å ±ãã
å ±ãã
ã³ã¡ã³ãæ¬ããã®äžã®å°çã ã£ãããããé°è¬è«è
ã¯äœæ
ã€ãã«ã¡ã¯ãã³ã«ç®ãã€ããã®ãã³ã¬ã¬ã¯ã«ã©ãã€
âŠæé èšäºã®è¢«å®³ã«ãã£ã
ä¿¡è ã®è«žåã«ã¯ãèŠèããç³ãäžããã
ãŸã æ²»éšäžã ãéããªããçã»ã³ããå°çšãã«ããçèªãã€ã€ããã
ã¯ãããããããâŠ
ä¿¡è ã®è«žåã«ã¯ãèŠèããç³ãäžããã
ãŸã æ²»éšäžã ãéããªããçã»ã³ããå°çšãã«ããçèªãã€ã€ããã
ã¯ãããããããâŠ
ãã€ãã«ã¡ã¯ãã³ããäžç°è°·ã¢ãã«ããªã©å»ã¯ã©ããã¯å®å
šã«éŠ¬é¹¿ã«ãããŠéç§åŠçãªãã®ããææ³è«äºãšããŠç¹å®ã®äººãã¡ã«æã¡äžããããŠãã®ãåé¡ã ãšæãã
éå²ãã®ããã«äœãå¹æã®æåŸ
ã§ããªãè¡æ¶²ã¯ã¬ã³ãžã³ã°ãçäºé²ãäžåŠæ²»çãããããçç¶ã«å¹ããšãç
œã£ãŠãã€ã³ãã«ãšã³ãµãŒãéå»ã«ãããããã ãããªããããããããããšãèµ·ããããªã
å¯çè«è¬ããŠã€ã«ã¹ã«å¹ãèš³ãªãããããã颚éªè¬ã§æ°Žè«ãæ²»ã話ã ãã
åã¯ã¯ãã³ã§ã€ãã«ã¡ã¯ãã³æã¯ãã®èšäºã«æžãããŠããããšã«å¯Ÿããæé ãšèšãã人é¡åæžã ã®ãã£ãŒãã¹ããŒãã ã®ãã«ã²ã€ããã©ãããã ã®èšãåºã
æåãããŸãšãã«äŒè©±ã§ãã人ã§ã¯ãªãã®ã
æåãããŸãšãã«äŒè©±ã§ãã人ã§ã¯ãªãã®ã
ãã€ã«ãªã£ããã€ãã«ã¡ã¯ãã³ä¿¡è
ã®äººéã¯ðŠ ã³ãããŠã€ã«ã¹ã¯ðª±å¯çè«ãããªãã£ãŠæ°ãã€ãã®ããªïŒ
ç·è«ã«å¯ŸããçŽ æŽãããé§è«è¬ãªã®ã«ããªãããããæã§åŸ¡èŒ¿ã«ãªã£ãŠããŸã£ãã®ãã BBC -
ãã£ã±ãæé ã ã£ããã ã
å¹æä¿¡ããŠå«ãã§ããã«ã«ã¯äŒããããªã
é°è¬è«æããã¢ã¿ãªã«ããããã©ãéã«ãã®è¬ã売ãããšããé°è¬ã®å¯èœæ§ã¯èããªããã ãã é ãããããã
å¹æä¿¡ããŠå«ãã§ããã«ã«ã¯äŒããããªã
é°è¬è«æããã¢ã¿ãªã«ããããã©ãéã«ãã®è¬ã売ãããšããé°è¬ã®å¯èœæ§ã¯èããªããã ãã é ãããããã
ã€ãã«ã¡ã¯ãã³æšãã®é£äžã®5幎åŸ10幎åŸãæ³åããŠã¿ãããã
ãã£ãšéããªãçºèšåããªãæªæ¥ã®SNSã§ç¡é§å£ã°ã£ããã ãã
ãã£ãšéããªãçºèšåããªãæªæ¥ã®SNSã§ç¡é§å£ã°ã£ããã ãã
æ¥æ¬ã§ããã®è¬ã®ååãããè³ã«ããŸãããå
ã
ã¯éŠ¬ã®è«äžãã®ããã«éçºãããè¬ã®ã¯ããã³ããã®ç¹å¹è¬ã ãªããŠãããçš®ã®éœåžäŒèª¬ããç¥ããŸããããã¢ã¡ãªã«ã§ãã€ã®ãªã¹ã§ãã©ãã©ãçåã®å£°ãäžãã£ãŠããŸãã
ãµããã»ã»ð¥±ð¥±ð¥±ð¥±
岞ç°ç·çãå±±é倧è£ãåŸè€å€§è£ãå å
倧è£ãæè€å€§è£
ã³ããç¹å¹æ²»çè¬ãã€ãã«ã¡ã¯ãã³ãè¬ä»£éå»äŸ¡ããåžžã«ç©è°ãä»ã¯äžçã®äžæµç§åŠè éå£ãå ¬åŒçºè¡šã€ã³ãæ¿åºãç¡æé åžããŠããã
ã³ããç¹å¹æ²»çè¬ãã€ãã«ã¡ã¯ãã³ãè¬ä»£éå»äŸ¡ããåžžã«ç©è°ãä»ã¯äžçã®äžæµç§åŠè éå£ãå ¬åŒçºè¡šã€ã³ãæ¿åºãç¡æé åžããŠããã
ãã®èšäº ã»äžå·ããŠãã人
BBCð©ïŒ
ã¬ã€ãã§ã«ã»ã·ã¥ã¬ã¢ããžã£ãã¯ã»ã°ãããã³ãBBCãªã¢ãªãã£ãŒã»ãã§ãã¯
ã€ãã«ã¡ã¯ãã³èãããããŒã ïŒ
ã®ããªã³ã»ãã€ã€ãŒãªãŠã£ããã»ã«ããå士
ãžã§ã€ã ãºã»ãã¶ãŒã¹å士
ããã¯ã»ãã©ãŠã³å士
BBCð©ïŒ
ã¬ã€ãã§ã«ã»ã·ã¥ã¬ã¢ããžã£ãã¯ã»ã°ãããã³ãBBCãªã¢ãªãã£ãŒã»ãã§ãã¯
ã€ãã«ã¡ã¯ãã³èãããããŒã ïŒ
ã®ããªã³ã»ãã€ã€ãŒãªãŠã£ããã»ã«ããå士
ãžã§ã€ã ãºã»ãã¶ãŒã¹å士
ããã¯ã»ãã©ãŠã³å士
ã³ã¡ã³ãæ¬ãå°çãªã®ã¯ ããã話ãªã®ã ãã©ããæ¥æ¬èªã®èªè§£åãã€ãã€ããªæ¹ãç§åŠãªãã©ã·ãŒãããã»ã©ã§ããªãæ¹ããããã¯ããããã»ãšãã©ããã®äž¡æ¹ã®æ¹ã
ãã³ã¡ã³ãæ¬ã«çµæ§åºãŠãããšãã
æ¥æ¬ã ããããªããäžçã§èµ·ãã£ãŠãã®ãäžæè°ã§ãããããªãã
æ°åã³ããæ²»çè¬åè£ãšããŠååãæãã£ãæ¢åã®è¬åã¯ããã€ãããã®ã«ããªãã§ã€ãã«ã¡ã¯ãã³ã°ããã«ä¿¡è
ã矀ãã£ããã ãããã
ãã€ãã®ãã€ãªã
ã¢ã«ããã©ãã«å£²ããããããªã
ã€ãã«ã¡ã¯ãã³ã§ã¯å²ãããªããããªã
ã€ãã§ã«å©æš©ã貪ããªããããªã
åæé®®ã®ããµã€ã«ãšäžç·ã ãªã
ã¢ã«ããã©ãã«å£²ããããããªã
ã€ãã«ã¡ã¯ãã³ã§ã¯å²ãããªããããªã
ã€ãã§ã«å©æš©ã貪ããªããããªã
åæé®®ã®ããµã€ã«ãšäžç·ã ãªã
BBCãåžžã«ããããèšäºæžããŠãããªãããªã
ã¡ãããšè£ã©ãããçµç·¯ãšçµæã§åºæ¥ãèšäºã
ã¡ãããšè£ã©ãããçµç·¯ãšçµæã§åºæ¥ãèšäºã
岞ç°ç·çãå±±é倧è£ãåŸè€å€§è£ãå å
倧è£ãæè€å€§è£
ã³ããç¹å¹æ²»çè¬ãã€ãã«ã¡ã¯ãã³ãè¬ä»£éå»äŸ¡ããåžžã«ç©è°ãä»ã¯äžçã®äžæµç§åŠè éå£ãå ¬åŒçºè¡šã€ã³ãæ¿åºãç¡æé åžããŠããã
ã³ããç¹å¹æ²»çè¬ãã€ãã«ã¡ã¯ãã³ãè¬ä»£éå»äŸ¡ããåžžã«ç©è°ãä»ã¯äžçã®äžæµç§åŠè éå£ãå ¬åŒçºè¡šã€ã³ãæ¿åºãç¡æé åžããŠããã
ä»æ¥ã€ã³ãããå±ãããç¬
ã€ãã«ã¡ã¯ãã³ãæ°åã³ããã«å¯ŸããŠæ¬åœã«å¹æã®ããç¹å¹è¬ã§ãã£ãã®ãªããã©ãã»ã©ã®äººãå©ãã£ããã»ã»ããšãŠãæ®å¿µã§ãã
å¯çè«è¬å¹ããªãéåœã®éçè
ã¯å°ãªãã¯ãð
æ¡ã®å®ããã«ã³ã¡ãã€ããŠãã
ïŒã€ãã«ã¡ã¯ãã³ã¯å¹ããäœãç§ãçŽåŸãããããšã¯ã§ããªã
ããâŠâŠãå蚌å¯èœæ§ããèªããªã人ãå士ãã£ãŠãŠè¯ãã®ïŒ(æ±)
ãç§ã¯ç§åŠçã«è°è«ããŸãããã£ãŠãã䞻匵ã ããã³ã¬âŠâŠ
å€ã®mixiã®æ°ŽäŒããã§ããã©ããªå®éšã§ã©ããªçµæãåºããèããå€ãããïŒãã¿ãããªâ
ããâŠâŠãå蚌å¯èœæ§ããèªããªã人ãå士ãã£ãŠãŠè¯ãã®ïŒ(æ±)
ãç§ã¯ç§åŠçã«è°è«ããŸãããã£ãŠãã䞻匵ã ããã³ã¬âŠâŠ
å€ã®mixiã®æ°ŽäŒããã§ããã©ããªå®éšã§ã©ããªçµæãåºããèããå€ãããïŒãã¿ãããªâ
æ¥æ¬èªã«èš³ãããèšäºã«ããã€ãã«ã¡ã¯ãã³ã¯å¹ãããïŒãã£ãŠäººãã¡ãããããã³ã¡ã³ãã€ããŠãŸããããè±èªãèªããããšãšå
容ãç解ã§ããããšã¯å¥ã ãšæããŸãã
ãã£ãããŒïŒæ¥æ¬èªçã ããŒïŒ
誀ã£ãç§åŠ&æäœéã®ç¥èœããæ¬ ããåã¯ã¯ã©ã
éå²ãã®çºã«åºæ¥ãããšð
ãã€ãã«ã¡ã¯ãã³ãCOVID-19ã«ããæ»ãé²ãããšã瀺ããããšäž»åŒµããèšåºè©Šéšã®äžã«ããæãããªæé ïŒãã€ããïŒã®å
åãããã¯ç 究ãç¡å¹ã«ããã»ã©ã®é倧ãªèª€ãããå«ãŸãªããã®ã¯ã1ã€ããªãã£ããã
ã©ã£ã¡ã®è©ãæã€ãšããããªããŠããã¯ã¯ãã³ã§éå²ããäŒãã§ãã人éãå¿
æ»ãã£ãŠèšã£ãŠã人ã£ãŠäœã§ã€ãã«ã¡ã¯ãã³ã§éå²ããäŒãã§ãã人éã®ååšã®å¯èœæ§ãçããªãã®ãããã
ããŸã å€æ°ã®ä¿¡è
ã ç±³ãè±ãEUã®ä¿å¥åœå±ã¯COVID-19察çãšããŠäœ¿çšããã«ã¯ååãªèšŒæ ããªããšã»ã€ãã«ã¡ã¯ãã³ããããç 究ã¯ç²Ÿæ»ã«èãããããã®ã§ã¯ãªãã»é£ã³ã€ããããããšããšã¯ã¯ã¯ãã³äžè¶³
æ¥æ¬èªã®èšäºããããŸããã
äœãæ¬åœã§äœãåããâ('ïœ`;)â
äžããªãã®ãäžçªã!?
äžããªãã®ãäžçªã!?
ãŸãã«é女ç©ããã人éãšåé¡ã
äžæãäžäºã§ç©äºãžã®æã蟌ã¿ã匷ã人éãªãã ãããª..ããèšãã°çé¢ç®ã飲ãã®ã¯åæã ãã©åŠæ¹ããªãå»åž«ãæ»æããã®ã¯éãããâŠ
äžæãäžäºã§ç©äºãžã®æã蟌ã¿ã匷ã人éãªãã ãããª..ããèšãã°çé¢ç®ã飲ãã®ã¯åæã ãã©åŠæ¹ããªãå»åž«ãæ»æããã®ã¯éãããâŠ
èå³æ·±ãèªã¿ç©
ã€ãã«ã¡ã¯ãã³æŽŸã£ãŠãæ··ä¹±ãçãããã«åºå·ããŠãããšããæãããæ²»çè¬ã¯ä»ã«ããããã
äžåœå ±ç£å ããéãè²°ã£ãŠãããããªãããã
äžåœå ±ç£å ããéãè²°ã£ãŠãããããªãããã
é°è¬è«ãä¿¡ããåŸåã«ãã人ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã蚌æ ãé èœãããŠããããã¯ã¯ãã³ã§å€ãã®æ»è
ãåºãŠãã蚌æ ãé èœãããŠãããã®äž¡æ¹ãä¿¡ããã¡ã ããããã€ãã«ã¡ã¯ãã³æšé²æŽŸããšãåã¯ã¯ãã³æŽŸããå
ŒããŠãã人ãå€ããã§ããããã
ð
è©ŠããŠã¿ãã ãã§ãé§ç®ãªã®ã¯äœæ ãªã®ã
ç®ç«ã£ãå¯åå¿ãå¯äœçšãç¡ã
å®äŸ¡ãªã€ãã«ã¡ã¯ãã³ã¯
å°çª®ããŠãã人ã ãæãã§ããã¯ã
è©Šãããã誀ã£ããšæå®ããæ¹ã
誀ã£ãŠãã
è©ŠããŠã¿ãã ãã§ãé§ç®ãªã®ã¯äœæ ãªã®ã
ç®ç«ã£ãå¯åå¿ãå¯äœçšãç¡ã
å®äŸ¡ãªã€ãã«ã¡ã¯ãã³ã¯
å°çª®ããŠãã人ã ãæãã§ããã¯ã
è©Šãããã誀ã£ããšæå®ããæ¹ã
誀ã£ãŠãã
BBC Japan 10/9(å) 11:04é
ä¿¡
ç 究çµæãèšããç®æã«ã€ããŠã¯(ãããè«æã£ãŠãããªã ãã)ã£ãŠå
·åã§æ®éã«èªãããã ãã©ãåã¯ã¯ãã³ãšãã€ãã«ã¡ã¯ãã³æšé²æŽŸã®ä»¶ã«é¢ããŠã¯æ°èå®æã®ã¬ããŒããèªãã§ãæ°åã«ãªã£ãã
å¹æã®æ©åºãäžæãªè¬ã£ãŠã®ãååšããŠããšããŠãããã£ããçåã ãããªã®ã«ãå»çé¢ä¿è
ãæšããã£ãŠã®ã¯äºéäžéã«èª€ã£ãŠããŸã£ãŠéšåãèµ·ãããŠãããšããããšã ããªã
ç§åŠè
ã§ã¯ãªãå®æ家ãåä¹ãã¹ãã§ã¯âŠ"ã©ããªèšŒæ ãããã°ã€ãã«ã¡ã¯ãã³ã¯å¹ããªããšçŽåŸããã®ããšåããããšãããŒãªãŒå士ã¯ãã€ãã«ã¡ã¯ãã³ã¯å¹ããäœãç§ãçŽåŸãããããšã¯ã§ããªãããšçãã"
BBCâ
誀ã£ãç§åŠãçãã æ°åãŠã€ã«ã¹ãç¹å¹è¬ã
ããã€ãã®èšåºããŒã¿ã玹ä»ãã€ã€ãæšé²æŽŸã®æ·±å»ãªèª€ããææã
ããã€ãã®èšåºããŒã¿ã玹ä»ãã€ã€ãæšé²æŽŸã®æ·±å»ãªèª€ããææã
çªç¶ã®ã€ãã«ã¡ã¯ãã³äžãããããŠãã§ã€ã¯ãã¥ãŒã¹
IVMã®èª€æ å ±ãæµããŠæ²»çã劚害ããŠæ£è ãæ»ãªãããšããŠèšŽãããããWHOã®ã¹ã¯ãããµã³ã¿ããã«ãªãã°ããã®ã«
IVMã®èª€æ å ±ãæµããŠæ²»çã劚害ããŠæ£è ãæ»ãªãããšããŠèšŽãããããWHOã®ã¹ã¯ãããµã³ã¿ããã«ãªãã°ããã®ã«
BBC 2021.10.9
ã€ãã«ã¡ã¯ãã³ã®æèš
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable | Nature Medicine
ã€ãã«ã¡ã¯ãã³ã®æèš
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable | Nature Medicine
BBCãã¥ãŒã¹ 2021.10.9
ã€ãã«ã¡ã¯ãã³ã®æèš
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable | Nature Medicine
ã€ãã«ã¡ã¯ãã³ã®æèš
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable | Nature Medicine
ãªãã»ã©ããããªèæ¯ããã£ãã®ããã¯ã¯ãã³äŸçµŠäžè¶³ãšã®é¢ä¿ãšãã
ã¡ã«ã¯ç€Ÿãæå¹æ§ãªããšãã£ãŠããæ°è¬ãåºããšãã£ãŠããã
ã¡ã«ã¯ç€Ÿãæå¹æ§ãªããšãã£ãŠããæ°è¬ãåºããšãã£ãŠããã
ã³ã¡ã³ãæ¬ãããå°ççµµå³ãããŠããããã
å¹æããããšããè«æå€æ°ã«ããŒã¿äžåãèŠã€ãããããŒã¿ãå
ã«ãæšå¥šããéæšå¥šã«è»¢ããå»åž«ã«å«ããããetcâŠ
æ¡ä»¶ã«ãã£ãŠã¯å¹ããªãè¯ãã®ã ãã©ãæšé²æŽŸãã«ã«ãåããŠãã®ããªãã
æ¡ä»¶ã«ãã£ãŠã¯å¹ããªãè¯ãã®ã ãã©ãæšé²æŽŸãã«ã«ãåããŠãã®ããªãã
ãCOVID-19ã«æå¹ã ãšããä¿¡é Œæ§ã®é«ãç 究ã¯ç¡ã
ã€ãã«ã¡ã¯ãã³ã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ã€ãã«ã¡ã¯ãã³ã«é¢ããäž»èŠãªæ²»éš26件ã®ãã¡ã3åã®1以äžã«ã€ããŠãæ·±å»ãªèª€ããäžæ£è¡çºããã£ãå¯èœæ§ãããããã以å€ã®æ²»éšã§ã¯ãã€ãã«ã¡ã¯ãã³ã®æå¹æ§ã瀺ã説åŸåã®ãã蚌æ ã¯åŸãããŠããªãã
ã€ãã³ã¡ã®ããããcovid19ãžã®ã€ãã«ã¡ã¯ãã³æšé²æŽŸããã
åéãã®æ¡å€§åçç£ããªããã匷å¶åé€ãã¹ãã ããã«ã
åéãã®æ¡å€§åçç£ããªããã匷å¶åé€ãã¹ãã ããã«ã
ã€ãã«ã¡ã¯ãã³ççæã®äººãã¡ã£ãŠãå
åŽã®å»åž«ããéåŽã®å»åž«ããšãè¬çšèªãã䜿ã£ãŠããã©ãã©ãã¿ãŠãã€ãã«ã¡ã¯ãã³ã®æ¹ãéåŽ(ÂŽã»Ïã»ïœ)
ã»åç 究ãè¡ãããå°åã®ä¿å¥æ©é¢ãç 究ãææ¡ããŠããªã ã«ã€ã«ã»ã·ã§ã«ããªãã¯å士
æã倧èŠæš¡ã§è³ªãé«ãã®ã¯ãã«ããã»ãã¯ãã¹ã¿ãŒå€§åŠã®ãã¥ã®ã£ã¶ãŒæ²»éšãããããã®ã ããã®ç 究ã§ããCOVID-19ã«å¯Ÿããå¹æã¯äœã確èªãããªãã£ãã
å¢ã é¢å¿
(2021.10.09 BBC)
æã倧èŠæš¡ã§è³ªãé«ãã®ã¯ãã«ããã»ãã¯ãã¹ã¿ãŒå€§åŠã®ãã¥ã®ã£ã¶ãŒæ²»éšãããããã®ã ããã®ç 究ã§ããCOVID-19ã«å¯Ÿããå¹æã¯äœã確èªãããªãã£ãã
å¢ã é¢å¿
(2021.10.09 BBC)
ã銬鹿ãªäººéãšç¬ã£ãŠãããããªããäœããããã©ãŒã®ãŠãã€äººè¿«å®³ã¯ããŒãŠã£ã³ã®é²åè«ã«åºã¥ããŠãããããèšãã銬鹿ã¯æŸçœ®ããŠãã¡ã ã空æ³ååŠã¯Steins;Gateã ãã«ããŠãããâ
ã³ããçŠã¯è¶çªçèšã倧æã¡ãã£ã¢ã¯ä¿¡çšã§ãããã®åé¡ã
ç§åŠçæ ¹æ ãªããç²ä¿¡ããã人ãã¡ã£ãŠãäœãã«ã€ããŠããã€é ãã奜ãã ããã
ã³ã¡æ¬ãã€ãã«ã¡ã¯ãã³ä¿¡è
ã§æº¢ãããã£ãŠææãèŠããã®ã§ããã
ã¡ãªã¿ã«èªåã¯ãã¡ã€ã¶ãŒã¯ã¯ãã³2åæ¥çš®æžã§ããç¹ã«äœãå¯äœçšãªã©ãããŸããã§ããã
ã¡ãªã¿ã«èªåã¯ãã¡ã€ã¶ãŒã¯ã¯ãã³2åæ¥çš®æžã§ããç¹ã«äœãå¯äœçšãªã©ãããŸããã§ããã
ã€ãã«ã¡ã¯ãã³ã«é¢ããŠãããŸã§çºè¡šãããç 究ã®äžã§ãæã倧èŠæš¡ã§è³ªãé«ãã®ã¯ãã«ããã»ãã¯ãã¹ã¿ãŒå€§åŠã®ãã¥ã®ã£ã¶ãŒæ²»éšãããããã®ã ããã®ç 究ã§ããCOVID-19ã«å¯Ÿããå¹æã¯äœã確èªãããªãã£ãã
å®éã«èšåºã§å€ãã®æ£è
ããã«äœ¿çšããŠãèå¹ã§ãããšããå€æã®å»åž«ãå€ãã
ããã¯ãçå±ã§ã¯æ²ããããªãäºå®ã§ãã
ãè«ãã蚌æ ãã§ãïŒ
ããã¯ãçå±ã§ã¯æ²ããããªãäºå®ã§ãã
ãè«ãã蚌æ ãã§ãïŒ
ã€ãã³ã¡æ¬ãå°ççµµå³
ã€ãã«ã¡ã¯ãã³èªäœã¯é·å¹Žãã¢ããªã«ãäžåç±³ã®æ²³å·ç²ç®çã«èŠãã人ã
ãæã£ãçŽ æŽãããè¬ãªã®ã«ãCovid-19é¢é£ã§å声ã«ã±ããä»ããã®ãäžæ«ã§ãªããªãã
äžèŠè³¢ãããªäººãããããæ°åã³ããã«ããã£ããäœãããªãããã¯ãã·ã ãšæãã®ã§ã€ãã«ã¡ã¯ãã³é£²ããã¿ãããªããšèšã£ãŠããã®ã§æ
匱ãããããã£ãŠæã£ãã
å¹ãå¹ããªãè°è«ã¯ããçµãã£ãŠã
ãå¹ããªãã
æªã æå¹æ§ã説ããŠã人ã¯æ 匱
圌ãã¯ã¯ã¯ãã³ããéããããã«ç²ä¿¡ããŠãããã«
ä»ã§ã¯ã¡ã«ã¯è£œãžã®æåŸ ããããŠããªã
å žåçãªããã¯ãã¡ã€ã¢å¹æã§ããw
ãå¹ããªãã
æªã æå¹æ§ã説ããŠã人ã¯æ 匱
圌ãã¯ã¯ã¯ãã³ããéããããã«ç²ä¿¡ããŠãããã«
ä»ã§ã¯ã¡ã«ã¯è£œãžã®æåŸ ããããŠããªã
å žåçãªããã¯ãã¡ã€ã¢å¹æã§ããw
ããããã°æ¥æ¬ã®æ²»éšã¯ã©ããããã ã£ãïŒ
ã€ãã«ã¡ã¯ãã³æšé²æŽŸã¯ããããèªåéã®èº«ã䜿ã£ãŠæ²»éšããŒã¿éãã«å¿é¡ããŠå¹æã蚌æããã°è¯ãããã«ãïœã§ã¯ãšéšãã ããªãè©æ¬ºåž«ã®æ¯èšãšå€ãããã
ãç 究ããšãããã®ã«ã€ããŠè²ã
ãªããšã瀺åããŠãããèšäºãã¡ã¢ã
æ¥é ã¯ã¯ãã³VS誀ç§åŠç¹å¹è¬ð
翻蚳ãããŠããââ
ã ããããããããŽãªæŒãã¯äžåœçµ¡ã¿ãªããã
äžåœç£ã¯ã¯ãã³ã®è©äŸ¡ãäœããŠå£²ããªãã£ããã次ã®æã£ãŠå¥Žã
äžåœç£ã¯ã¯ãã³ã®è©äŸ¡ãäœããŠå£²ããªãã£ããã次ã®æã£ãŠå¥Žã
ããããŒåŠšå®³ (*ïœç¿ÂŽ*)
é·ã ãšãå¿ æ»ããªïœ
éäžã§èªãã®ããããã
é·ã ãšãå¿ æ»ããªïœ
éäžã§èªãã®ããããã
ã€ããŒãã¥ãŒã¹ã«ããªã£ãŠã
誀ã£ãç§åŠã«ããæ²»éšãé²ãã§ããã€ãã«ã¡ã¯ãã³ã
é床ãªåã€ãã«ã¡ã¯ãã³æšãããªããªããªãã®ã
楜ããèªãŸããŠããã ããŸããð
é床ãªåã€ãã«ã¡ã¯ãã³æšãããªããªããªãã®ã
楜ããèªãŸããŠããã ããŸããð
ã€ãã«ã¡ã¯ãã³ã¯æ°åã³ãããŠã€ã«ã¹ææçã«ãå¹æããããšæããŸããâïž
ã€ãã«ã¡ã¯ãã³ãã³ããã«å¹ãã£ãŠä¿¡ããŠã人ãæ°ŽçŽ æ°Žãšãä¿¡ããŠãã
BBCããð æ çãããã£ãœã©å®å
šã§å¹æãå®çžŸãæãã®ã«ããã£ãœã©æ²»ãäºãåé¡ã¿ãããªãã¬ãã£ããªèšäºâŒïž ð€ð¢ ã ãããªãã ã£ãŠæãã§ããâŒïžð
ã€ãã«ã¡ã¯ãã³çã®å¥Žãšã¯ä»²è¯ããªããªãã
ã ãšã
æ æšã®ããŒçãã²å·Šç¿Œå»è
ããšåæã¯é°è¬è«è
ã ã£ãã
çžå€ãããã®BBCã»ã»ã»
ã€ãã«ã¡ã¯ãã³ã«å¹æããªããšããã®ãªããååŠæ§é ãã»ãŒäžèŽã®ã¡ã«ã¯ç€Ÿã®æ²»çè¬ã ã£ãŠå¹æããªãã£ãŠäºãããð
ã¯ã¯ãã³äººæ°ãè¡°ããŠãããããä»åºŠã¯ã€ãã«ã¡ã¯ãã³äžãïŒã¡ã«ã¯æ²»çè¬äžãã«æåéå§
ã€ãã«ã¡ã¯ãã³ã«å¹æããªããšããã®ãªããååŠæ§é ãã»ãŒäžèŽã®ã¡ã«ã¯ç€Ÿã®æ²»çè¬ã ã£ãŠå¹æããªãã£ãŠäºãããð
ã¯ã¯ãã³äººæ°ãè¡°ããŠãããããä»åºŠã¯ã€ãã«ã¡ã¯ãã³äžãïŒã¡ã«ã¯æ²»çè¬äžãã«æåéå§
ãªãã§ããŸã ã«å æé¢ä¿äžæã®ãŸãŸãæ»è
ãåºãç¶ããã¯ã¯ãã³ã¯å¯èœæ§ãæ·±æãããªãã§ããã ã®åº¶æ°è¬ã°ããå©ãã®ãç解äžæ :
ããããã®ãç¡äœçºãšã¯åŒã°ãªããã
ãæ°å€ããæªãã人ã ã¯ãã©ã»ãã®ã°ã«ãŒãã«å ¥ããããæ°å€ããããã人ã ãã€ãã«ã¡ã¯ãã³ã®ã°ã«ãŒãã«æ¯ãåããããŠãããã
äžæŠä¿¡ãããã®ãåŠå®ããã®ã¯ç°¡åã§ã¯ãªããªã
ãæ°å€ããæªãã人ã ã¯ãã©ã»ãã®ã°ã«ãŒãã«å ¥ããããæ°å€ããããã人ã ãã€ãã«ã¡ã¯ãã³ã®ã°ã«ãŒãã«æ¯ãåããããŠãããã
äžæŠä¿¡ãããã®ãåŠå®ããã®ã¯ç°¡åã§ã¯ãªããªã
ãBBCã®åæã§ããã®è¬ãæšé²ããŠãã人ã
ãæ ¹æ ãšããŠããå€ãã®éèŠãªç 究ã«ã¯ãæ·±å»ãªèª€ããããããšãæããã«ãªã£ãŠãããã
ç 究è
ã¯ããŒãã«è³ã®æ§ãªäžççå声ã欲ãããŠããŒã¿æé ãå«ããäžæ£è«æãæçš¿ããŠããïŒ
åçŸæ§ã®ãªãç§åŠè«æã¯ããããå¿ ãåãã°ããã®ã«ã
åçŸæ§ã®ãªãç§åŠè«æã¯ããããå¿ ãåãã°ããã®ã«ã